![James Fortune](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Fortune
No open positions remaining
Profile
James Fortune worked as a Principal at Johnson & Johnson.
He then served as the Chief Operating Officer at Access Closure, Inc. from 2008 to 2010.
After that, he worked as the Chief Operating Officer at Confluent Surgical, Inc., Augmenix, Inc., Intrinsic Therapeutics, Inc., and Ostial Corp.
In 2017 to 2018, he was the Chief Accounting & Operating Officer at Ocular Therapeutix, Inc. Mr. Fortune received his undergraduate degree from Rensselaer Polytechnic Institute.
Former positions of James Fortune
| Companies | Position | End |
|---|---|---|
Augmenix, Inc.
 Augmenix, Inc. Medical SpecialtiesHealth Technology Develops hydrogel technology to improve outcomes in radiation oncology and surgery | Chief Operating Officer | 2014-03-31 |
Access Closure, Inc.
 Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States | Chief Operating Officer | 2009-12-31 |
| OCULAR THERAPEUTIX, INC. | Director of Finance/CFO | 2017-04-05 |
Ostial Corp.
 Ostial Corp. Medical/Nursing ServicesHealth Services Develops catheter-based delivery system combined with a bare metal stent | Chief Operating Officer | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Training of James Fortune
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Access Closure, Inc.
Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States | Health Technology |
Confluent Surgical, Inc.
 Confluent Surgical, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Augmenix, Inc.
Augmenix, Inc. Medical SpecialtiesHealth Technology Develops hydrogel technology to improve outcomes in radiation oncology and surgery | Health Technology |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intrinsic Therapeutics, Inc.
 Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops device-based therapies for soft-tissue injuries of the spine | Health Technology |
Ostial Corp.
Ostial Corp. Medical/Nursing ServicesHealth Services Develops catheter-based delivery system combined with a bare metal stent | Health Services |
- Stock Market
- Insiders
- James Fortune
